Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
8,525 total articles
Tencent is set to benefit from Beijing's renewed emphasis on domestic tech services and a looser stance on high-end AI chip imports. At a $717B market cap and a P/E of ~23.5, Tencent offers a blend of growth (cloud, FinTech, games) and cash flow stability. We favor a long trade with a clear entry, stop and target tied to observable technical and po…
Chemours (CC) looks set to re-rate in 2026 as tight supply for high-purity hydrofluoroethers, steady demand for Opteon refrigerants, and improving technical momentum combine with a cheap starting valuation versus enterprise value. We present a long trade with entry at $15.10, stop at $13.00 and a $22.00 target over a 46-180 trading day time frame.
Cullinan Therapeutics (CGEM) is a clinical-stage oncology and immuno-immunology developer trading at roughly $700M market cap while sitting on a substantial cash reserve. With CLN-978 advancing toward clinical readouts, a positive zipalertinib trajectory and a reported cash runway into 2028, Cullinan offers an asymmetric long opportunity: the marke…
General Mills is trading like a broken consumer staples play despite healthy cash flow, a double-digit return on equity, and a 5%+ dividend yield. This trade idea lays out a swing trade to take advantage of excessive pessimism while keeping tight risk controls below recent support.
Exelixis (EXEL) is a profitable oncology company trading near $42.67 with solid free cash flow, low leverage and a pipeline catalyst in zanzalintinib. A favorable FDA outcome could push the stock toward the mid-$40s to $50s; the trade below balances upside with a clear stop and a mid-term time horizon tied to a likely near-term regulatory event.
QuantumScape has moved beyond lab headlines into real vehicle testing and pilot production. With a market cap near $6.0B and a string of OEM and materials partnerships, the risk/reward favors a disciplined long position that targets bet-the-technology upside while protecting capital against execution failure.
Intuitive Machines (LUNR) has run hard into my prior price target after closing the Lanteris acquisition and posting strong market momentum. Fundamentals haven't caught up to the rally: elevated price-to-sales (~13x), negative free cash flow, and persistent insider selling. This trade idea recommends a measured short/momentum-fade entry at $22.81 w…
Hims & Hers ($HIMS) is trading near recent lows with strong fundamental levers and a crowded short base. Valuation looks demanding on some metrics but the risk/reward is attractive for an aggressive, defined-risk long over the next 45 trading days. Entry, stop and target included.
Aurora (AUR) is trading like a story stock priced for huge autonomous-vehicle success while sitting on a modest cash runway and nascent commercial revenue. The company has moved from lab to paid operations in trucking; that operational progress plus AI tailwinds create a mid-term trade opportunity. This idea is aggressive: enter at $4.50, target $6…
Okta sits squarely at the intersection of identity and emergent enterprise AI agents. Identity is a prerequisite for secure agent actions; that makes Okta a natural beneficiary if customers adopt agentic workflows widely. Valuation already reflects a pullback from the 52-week high and a $1 billion buyback set to cushion share count. This trade targ…
Alico (ALCO) is a small-cap agricultural holding that is quietly pivoting from pure citrus production toward land management and real estate monetization. With a newly expanded $95M credit facility, a dedicated EVP of Real Estate, and management guidance for ~$20M in land sales this fiscal year, the stock looks positioned for a re-rating if managem…
Mercado Libre (MELI) is the dominant e-commerce and fintech platform across Latin America. With rising transaction take-rates, accelerating fintech adoption, and $8.61B in free cash flow, MELI offers a compounding growth story. This trade idea lays out an actionable long trade with entry at $2270.23, a $2850 target and a $2000 stop loss over a long…
Dycom's pivot into data-center electrical work and a record backlog make a compelling tactical long. The balance sheet, free cash flow and recent operational beats underwrite a trade that targets continued contract wins and integration upside from Power Solutions. This is a risk-managed idea — entry at $372, stop $350, target $420 — with clear trig…
Papa John's (PZZA) trades ~44% below Apollo's prior $64 bid and offers an asymmetric risk/reward for a long trade. The chain has real cash generation, a >5% yield, and active-market interest; the stock is technically oversold. This trade targets a recovery toward takeover levels while protecting capital if the turnaround stalls.
Canadian Solar (CSIQ) is positioned to monetize accelerating AI-related power needs through battery energy storage systems (BESS) and long-term project agreements. The market is only beginning to price that optionality; however, high cyclicality, execution risk in project development, and heavy short interest mean multiple expansion is likely to co…
Stifel Financial's recent 3-for-2 stock split and 11% dividend increase come at a time of strong free cash flow, modest leverage and improving fee mix. At $125.36 today, the stock offers a tactical long entry targeting a move toward $150 over the next 180 trading days, with a disciplined stop at $118 to protect against an industry-wide drawdown.
Appian has shown clearer signs of revenue resilience, improved cost efficiency, and practical AI-driven product traction. The shares trade at about $30 with a market cap near $2.2B — not a deep value bargain — but a disciplined long with a tight stop captures asymmetric upside if execution continues. We lay out an entry, stop and target for a mid-t…
<p>BigBear.ai is using product breadth - Observe, Orient and Dominate - to push beyond its defense and intelligence roots into larger commercial markets. That pivot could reduce revenue volatility from lumpy government contracts and create a clearer path to recurring SaaS-like revenue. The risk/reward is asymmetric now: shares trade around $6.02 wi…
Toyota (TM) is trading at a modest multiple, pays a 2.5% yield, and sits on clear near-term catalysts — from auto-show exposure to strengthening demand for fuel-cell and ICE hybrids. Technicals are mixed, but fundamentals and valuation give a favorable asymmetric trade. This idea outlines an entry at $219.00, a stop at $205.00 and a first target of…
<p>POET Technologies plunged after a secondary offering but the equity now trades at a level that understates its cash buffer and product momentum. With cash north of $300M, recent production orders and initial AI-focused products shipping, the current pullback is an actionable entry for disciplined traders willing to accept execution and adoption …
Vistra (VST) appears to be experiencing a headline-driven retreat rather than a fundamental slowdown. Power contracts and cash flow remain intact, but accounting line items tied to asset closure and decommissioning can compress reported earnings and spook short-term holders. This trade targets a mean reversion back above the 50-day SMA with a clear…
NIQ Global Intelligence is converting solid free cash flow into a cleaner earnings profile. The setup today favors a long trade: entry at $17.40, stop at $15.50 and a $21.00 target over a 180-trading-day window, betting on continued margin expansion and client spend resilience.
Franco-Nevada (FNV) offers exposure to gold and other commodities through a large, diversified royalties and streams portfolio. The stock trades near 52-week highs after a 16% dividend bump and board succession news; fundamentals (free cash flow of $340.5M, market cap ~$51B) point to durable cash conversion but also very rich multiples. This trade …
Unilever (UL) is a diversified consumer staples compounder with a 3.27% yield, stable cash flow, and exposure to growing personal care and hygiene markets. The stock is trading close to near-term technical support (SMA50/$65.64 area) after recent firmness in fundamentals and category tailwinds. This trade idea outlines a buy-on-weakness entry, expl…
Aura Biosciences is a clinical-stage oncology name with a liquid balance sheet and a stock that’s acting like a moving target. Shares are drifting near the mid-$5s with bullish MACD momentum, while short interest remains elevated with a high days-to-cover. This trade idea leans long for a tactical move higher, using tight risk controls and well-def…
